As of 2024-12-14, the Relative Valuation of Britannia Life Sciences Inc (BLAB.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.06 CAD, the upside of Britannia Life Sciences Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2024-12-10 | -1.56 |
| 2024-12-04 | -1.42 |
| 2024-12-02 | -1.42 |
| 2024-11-29 | -1.42 |
| 2024-11-28 | -1.42 |
| 2024-11-26 | -1.28 |
| 2024-11-25 | -1.99 |
| 2024-11-22 | -1.42 |
| 2024-11-21 | -1.13 |
| 2024-11-20 | -1.13 |
| 2024-11-19 | -1.13 |
| 2024-11-18 | -1.42 |
| 2024-11-15 | -0.85 |
| 2024-11-12 | -1.13 |
| 2024-11-08 | -1.42 |
| 2024-11-05 | -1.13 |
| 2024-11-04 | -1.13 |
| 2024-11-01 | -1.13 |
| 2024-10-30 | -1.42 |
| 2024-10-29 | -1.42 |
| 2024-10-28 | -1.42 |
| 2024-10-22 | -1.56 |
| 2024-10-21 | -2.84 |
| 2024-10-18 | -1.70 |
| 2024-10-17 | -1.70 |
| 2024-10-09 | -1.84 |
| 2024-10-08 | -1.70 |
| 2024-10-07 | -1.99 |
| 2024-10-04 | -1.70 |
| 2024-10-03 | -2.41 |
| 2024-10-01 | -1.70 |
| 2024-09-27 | -1.70 |
| 2024-09-26 | -1.70 |
| 2024-09-25 | -1.70 |
| 2024-09-23 | -1.70 |
| 2024-09-20 | -1.70 |
| 2024-09-19 | -1.70 |
| 2024-09-18 | -1.13 |
| 2024-09-17 | -1.70 |
| 2024-09-16 | -1.70 |